Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Elpida Therapeutics SPC

United States 16501 Ventura Boulevard Suite 400, 91436-2067, United States

About the sponsor

The sponsor concentrates on Hereditary Spastic Paraplegia Type 50, a rare inherited disorder affecting motor pathways.

  • Pathophysiology of SPG50
  • Biomarker identification for disease progression
  • Patient stratification based on genetic variants

Research aims to deepen understanding of disease mechanisms to guide therapeutic development.

About Specializations

Elpida Therapeutics SPC runs clinical trials in conditions such as Hereditary spastic paraplegia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Hereditary spastic paraplegia

Recruiting

Phase IIb Open‑Label Study of Intrathecal Melpida (AAV9/AP4M1) in Patients with Hereditary Spastic Paraplegia Type 50 (SPG50)

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Sponsor:Elpida Therapeutics SPC

Hereditary spastic paraplegia

Not yet recruiting

Study of melpida with drug combination in patients with Hereditary Spastic Paraplegia Type 50 (SPG50)

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Codeine Phosphate
  • Sponsor:Elpida Therapeutics SPC

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.